Work

The CAR-Hematotox Score As a Prognostic Model of Toxicity and Response in Patients Receiving BCMA-Directed CAR-T for Relapsed/Refractory Multiple Myeloma

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-165266

Authors: Kai Rejeski, Doris K. Hansen, Radhika Bansal, Pierre Sesques, Sikander Ailawadhi, Jennifer M. Logue, Ciara L. Freeman, Melissa Alsina, Sebastian Theurich, Frederick L. Locke, Emmanuel Bachy, Michael D. Jain, Yi Lin, Marion Subklewe

Institutions: LMU Klinikum, Ludwig-Maximilians-Universität München, Moffitt Cancer Center, Mayo Clinic, Hospices Civils de Lyon, Hôpital Lyon Sud, Mayo Clinic in Florida

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310089976

FWCI: 1.807

Cites:

Cited by: 25

Related to: 10